Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
Clifford
David B
DB
Department of Neurology, Washington University in St Louis, Saint Louis, MO 63110, USA. cliffordd@neuro.wustl.edu
De Luca
Andrea
A
DeLuca
Andrea
A
Simpson
David M
DM
Arendt
Gabriele
G
Giovannoni
Gavin
G
Nath
Avindra
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069442:Natalizumab